Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $128.3600 (-3.12%) ($128.2000 - $135.6100) on Mon. Dec. 24, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.19% (three month average) | RSI | 18 | Latest Price | $128.3600(-3.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -6.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(55%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.595% in a week (0% probabilities). TLT(-16%) VXX(-15%) VIXM(-11%) UUP(-9%) DIA(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.595% (StdDev 3.19%) | Hourly BBV | 0 () | Intraday Trend | -2.9% | | | |
|
Resistance Level | $145.72 | 5 Day Moving Average | $132.63(-3.22%) | 10 Day Moving Average | $136.53(-5.98%) | 20 Day Moving Average | $145.72(-11.91%) | To recent high | -53.2% | To recent low | 0% | Market Cap | $2.063b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |